Mitsui Chemicals stock gets a fresh valuation update

Published on 10/08/2026 at 03:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

AnalystHighTarget lifted its fair value from JPY 3,533.02 to JPY 3,546.24 on October 6, 2026. Tokyo trading put the shares at JPY 2,125 on October 8.

Mitsui Chemicals, JP3888300005, Illustration mit AI erstellt.

Mitsui Chemicals stock (ISIN JP3888300005) was trading at JPY 2,125 on the Tokyo Stock Exchange on October 8, 2026 at 10:40 a.m. JST, down 1.78 percent from the prior close of JPY 2,163.50. A valuation update from Simply Wall St on October 6, 2026, puts the fair value discussion above the current market quotation.

Fair value rises to JPY 3,546.24

According to Simply Wall St, AnalystHighTarget increased its fair value estimate from JPY 3,533.02 to JPY 3,546.24 per share on October 6, 2026. The new figure stands 66.9 percent above the JPY 2,125 market price, although the platform describes the estimate as exploratory rather than a formal investment recommendation.

The update emphasizes balance-sheet cleanup, capital returns and improvements in Basic and Green Materials and Life and Healthcare Solutions. It also identifies the US$900 million oral care platform at MC Dental Holdings America as a route to revenue growth and higher margins.

Life sciences adds a second angle

Mitsui Chemicals announced on October 5, 2026, that it had launched InnoCell P-Type as of October 1. The company says the oxygen-permeable culture plate is designed to support organoid research, improve tissue-model reproducibility and increase the precision of drug efficacy and toxicity testing, according to the Mitsui Chemicals release.

The product expands the company's life-sciences exposure beyond its established chemicals portfolio. Its commercial contribution is not quantified in the release, so the immediate market case still rests more directly on valuation assumptions and the broader earnings mix.

Market value and yearly range

Mitsui Chemicals had a market capitalization of JPY 782.2 billion on October 8, 2026, with 418,600 shares traded by the quoted time. The JPY 2,125 price was 14.2 percent below the 52-week high of JPY 2,477.50 and above the 52-week low of JPY 1,737.

Shares outstanding totaled 378.07 million as of September 25, 2026, unchanged from the prior year, according to Eulerpool. That stable share count gives the valuation update a direct per-share reference, while the current quotation remains below both the fair value estimate and the yearly high.